SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-038926
Filing Date
2022-06-23
Accepted
2022-06-23 16:49:47
Documents
2
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3869
2 POA DOCUMENT poa.txt EX-24 3601
  Complete submission text file 0001209191-22-038926.txt   8925
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Szela Mary T (Reporting) CIK: 0001410289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37620 | Film No.: 221036058

Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences